200 related articles for article (PubMed ID: 21693629)
1. A role for the low-affinity A2B adenosine receptor in regulating superoxide generation by murine neutrophils.
van der Hoeven D; Wan TC; Gizewski ET; Kreckler LM; Maas JE; Van Orman J; Ravid K; Auchampach JA
J Pharmacol Exp Ther; 2011 Sep; 338(3):1004-12. PubMed ID: 21693629
[TBL] [Abstract][Full Text] [Related]
2. Activation of the A(3) adenosine receptor suppresses superoxide production and chemotaxis of mouse bone marrow neutrophils.
van der Hoeven D; Wan TC; Auchampach JA
Mol Pharmacol; 2008 Sep; 74(3):685-96. PubMed ID: 18583455
[TBL] [Abstract][Full Text] [Related]
3. Adenosine inhibits tumor necrosis factor-alpha release from mouse peritoneal macrophages via A2A and A2B but not the A3 adenosine receptor.
Kreckler LM; Wan TC; Ge ZD; Auchampach JA
J Pharmacol Exp Ther; 2006 Apr; 317(1):172-80. PubMed ID: 16339914
[TBL] [Abstract][Full Text] [Related]
4. Activation of the A(3) adenosine receptor inhibits fMLP-induced Rac activation in mouse bone marrow neutrophils.
van der Hoeven D; Gizewski ET; Auchampach JA
Biochem Pharmacol; 2010 Jun; 79(11):1667-73. PubMed ID: 20149782
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of adenosine A2a and A2b receptors on cardiac contractility.
Chandrasekera PC; McIntosh VJ; Cao FX; Lasley RD
Am J Physiol Heart Circ Physiol; 2010 Dec; 299(6):H2082-9. PubMed ID: 20935155
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the A2B adenosine receptor from mouse, rabbit, and dog.
Auchampach JA; Kreckler LM; Wan TC; Maas JE; van der Hoeven D; Gizewski E; Narayanan J; Maas GE
J Pharmacol Exp Ther; 2009 Apr; 329(1):2-13. PubMed ID: 19141710
[TBL] [Abstract][Full Text] [Related]
7. Probing biased/partial agonism at the G protein-coupled A(2B) adenosine receptor.
Gao ZG; Balasubramanian R; Kiselev E; Wei Q; Jacobson KA
Biochem Pharmacol; 2014 Aug; 90(3):297-306. PubMed ID: 24853985
[TBL] [Abstract][Full Text] [Related]
8. Allosteric modulators of human A2B adenosine receptor.
Trincavelli ML; Giacomelli C; Daniele S; Taliani S; Cosimelli B; Laneri S; Severi E; Barresi E; Pugliesi I; Greco G; Novellino E; Da Settimo F; Martini C
Biochim Biophys Acta; 2014 Mar; 1840(3):1194-203. PubMed ID: 24361612
[TBL] [Abstract][Full Text] [Related]
9. Concurrent agonism of adenosine A2B and glucocorticoid receptors in human airway epithelial cells cooperatively induces genes with anti-inflammatory potential: a novel approach to treat chronic obstructive pulmonary disease.
Greer S; Page CW; Joshi T; Yan D; Newton R; Giembycz MA
J Pharmacol Exp Ther; 2013 Sep; 346(3):473-85. PubMed ID: 23820127
[TBL] [Abstract][Full Text] [Related]
10. Adenosine augments IL-10 production by microglial cells through an A2B adenosine receptor-mediated process.
Koscsó B; Csóka B; Selmeczy Z; Himer L; Pacher P; Virág L; Haskó G
J Immunol; 2012 Jan; 188(1):445-53. PubMed ID: 22116830
[TBL] [Abstract][Full Text] [Related]
11. BAY60-6583 acts as a partial agonist at adenosine A2B receptors.
Hinz S; Lacher SK; Seibt BF; Müller CE
J Pharmacol Exp Ther; 2014 Jun; 349(3):427-36. PubMed ID: 24633424
[TBL] [Abstract][Full Text] [Related]
12. Adenosine A2B receptor blockade slows growth of bladder and breast tumors.
Cekic C; Sag D; Li Y; Theodorescu D; Strieter RM; Linden J
J Immunol; 2012 Jan; 188(1):198-205. PubMed ID: 22116822
[TBL] [Abstract][Full Text] [Related]
13. Adenosine receptor A2b on hematopoietic cells mediates LPS-induced migration of PMNs into the lung interstitium.
Konrad FM; Witte E; Vollmer I; Stark S; Reutershan J
Am J Physiol Lung Cell Mol Physiol; 2012 Sep; 303(5):L425-38. PubMed ID: 22707616
[TBL] [Abstract][Full Text] [Related]
14. Both A2a and A2b adenosine receptors at reperfusion are necessary to reduce infarct size in mouse hearts.
Methner C; Schmidt K; Cohen MV; Downey JM; Krieg T
Am J Physiol Heart Circ Physiol; 2010 Oct; 299(4):H1262-4. PubMed ID: 20709859
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the PGE receptor subtype mediating inhibition of superoxide production in human neutrophils.
Talpain E; Armstrong RA; Coleman RA; Vardey CJ
Br J Pharmacol; 1995 Apr; 114(7):1459-65. PubMed ID: 7606349
[TBL] [Abstract][Full Text] [Related]
16. Investigation of the inhibitory effects of PGE2 and selective EP agonists on chemotaxis of human neutrophils.
Armstrong RA
Br J Pharmacol; 1995 Dec; 116(7):2903-8. PubMed ID: 8680723
[TBL] [Abstract][Full Text] [Related]
17. Adenosine A2b receptors control A1 receptor-mediated inhibition of synaptic transmission in the mouse hippocampus.
Gonçalves FQ; Pires J; Pliassova A; Beleza R; Lemos C; Marques JM; Rodrigues RJ; Canas PM; Köfalvi A; Cunha RA; Rial D
Eur J Neurosci; 2015 Apr; 41(7):878-88. PubMed ID: 25704806
[TBL] [Abstract][Full Text] [Related]
18. Effect of cyclic AMP level reduction on human neutrophil responses to formylated peptides.
Spisani S; Pareschi MC; Buzzi M; Colamussi ML; Biondi C; Traniello S; Pagani Zecchini G; Paglialunga Paradisi M; Torrini I; Ferretti ME
Cell Signal; 1996 Jun; 8(4):269-77. PubMed ID: 8842527
[TBL] [Abstract][Full Text] [Related]
19. The adenosine/neutrophil paradox resolved: human neutrophils possess both A1 and A2 receptors that promote chemotaxis and inhibit O2 generation, respectively.
Cronstein BN; Daguma L; Nichols D; Hutchison AJ; Williams M
J Clin Invest; 1990 Apr; 85(4):1150-7. PubMed ID: 2156895
[TBL] [Abstract][Full Text] [Related]
20. Migration of neutrophils from blood to tissue: alteration of modulatory effects of prostanoid on superoxide generation in rabbits and humans.
Kanamori Y; Niwa M; Kohno K; Al-Essa LY; Matsuno H; Kozawa O; Uematsu T
Life Sci; 1997; 60(16):1407-17. PubMed ID: 9096262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
